For example, Cowen et al.68 reported that a Ki67 score of >3.5% (Ki67 high) in pre-treatment prostate cancer biopsies was strongly associated with higher rates of biochemical failure after conventional dose RT for prostate cancer. This evidence concerns the gene MKI67 and prostate carcinoma.